enCore Energy
Extract U3O8 via ISR from South Texas central processing plants (Rosita, Alta Mesa) and sell into a book of US utility sales agreements that are spot-price-referenced with a mix of market, hybrid, base-escalated and fixed pricing; supplemented by asset sales and a marketable-securities portfolio.
Earnings, margins, COGS & capex
A pre-scale producer whose reported profits are dominated by non-operating items. Q1 FY2026's return to profit ($5.4M net income, $0.03 EPS, vs a $24.2M net loss in Q1 FY2025) was driven by a $34.4M gain on the sale of its New Mexico mineral assets to Verdera Energy, partly offset by a $10.0M unrealized loss on marketable securities - not by uranium margins, which sat near breakeven. Underlying operations remain unprofitable while the company invests to lift volumes; the FY2024 $67.99M net loss ($61.4M attributable) and internal-control material-weakness disclosure triggered a ~46% one-day share crash and securities litigation.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~99¢ is cost of goods and ~0¢ operating expense, leaving ~1¢ of operating profit (~0¢ net).
Revenue trend
Margins
up from $62.89/lb in Q1 FY2025
up from $62.97/lb Q1 FY2025 - cost slightly above realized price
up from $31.26/lb YoY
vs $45.62/lb Q1 FY2025
narrowed from $(0.34) FY2024; FY2024 net loss attributable $61.4M
COGS structure
Cost of uranium sold is dominated by (a) cash extraction cost ($34.94/lb Q1 FY2026, well-field ISR operating cost), (b) non-cash extraction/depletion/fees (~$11.49/lb), and (c) purchased pounds bought to satisfy contracted deliveries when own production lags (180,000 lb at $78.82/lb in Q1 FY2026) - the purchased-pound drag is what pushes total delivered cost ($68.02/lb) to just above realized price.
Capex
Growth-stage: well-field development, satellite ion-exchange plants (e.g., Upper Spring Creek IX plant completed 2026-06-04), and central-plant expansion in South Texas. Funded partly by the $115M 5.50% convertible notes closed 2025-08-22 (net $109.8M, of which $11.5M funded capped calls and ~$10.6M repaid the prior loan agreement). FY capex figure not disclosed in Q1 release.
Latest earnings
Return to GAAP profit ($0.03 EPS vs $(0.13) YoY), but the swing was driven by a $34.4M New Mexico asset-sale gain, not operating margin - a low-quality beat
No explicit full-year 2026 production or revenue guidance in the Q1 release; management emphasized cost reduction, permitting acceleration and potential sector consolidation over forward projections
- U3O8 delivered (Q1 FY2026)
- 270,000 lb at $67.78/lb
- U3O8 extracted (Q1 FY2026)
- 90,000 lb (+22% YoY)
- Purchased pounds (Q1 FY2026)
- 180,000 lb at $78.82/lb
- Ending U3O8 inventory
- 153,956 lb at $64.52/lb
- Cash / total liquidity
- $41.6M cash / $84.7M liquidity
- Cash extraction cost
- $34.94/lb
Growth drivers
- Ramp of extracted volume — 699,807 lb U3O8 in FY2025 (+242% YoY), targeting 3M lb/yr within 3 years and 5M lb/yr within 5 years
- New satellite/central plant capacity in South Texas (Alta Mesa, Rosita, Upper Spring Creek) converting resources to flowing production
- Contract book of ~8.3M lb committed 2025-2033 across twelve US-utility sales agreements (per FY2024 10-K), with optionality to add ~2.2M lb, using a mix of market, hybrid, base-escalated and fixed pricing
- US domestic-supply tailwind - utility and federal push to source uranium outside Russia/Kazakhstan
Reported financials — SEC EDGAR
Audited GAAP figures pulled from SEC filings · latest filing 2026-03-31. The audited primary-source spine — not financial advice.
Revenue — annual (GAAP)
Margins & balance sheet — FY’25
Bull & bear
The only pure-play, at-scale US ISR uranium producer with a licensed two-plant base, a multi-million-pound contracted book, and a distressed valuation (~$257M market cap, ~6x TTM sales) that has priced in the governance crisis - leaving upside if the production ramp and uranium price cooperate.
- Production base is real and licensed: 699,807 lb extracted in FY2025 (+242%), the hardest asset to replicate in US uranium - peers are years behind on permitting and on drummed volume
- Valuation reset ~74% off 2024 highs bakes in the material-weakness/litigation overhang; a clean turnaround under new leadership could re-rate toward peers
- Cash extraction cost $34.94/lb vs $70+/lb spot means genuine unit economics exist once own-production covers the contract book (removing purchased-pound dilution)
- Structural US-domestic-uranium demand: utilities and federal policy actively sourcing non-Russian/Kazakh supply, a multi-year tailwind
- Balance-sheet optionality ($84.7M liquidity, 23.8M-share URG stake, retained Verdera equity) funds the ramp and provides M&A currency in a consolidating sector
A serially loss-making producer whose latest 'profit' came from selling assets, still under a securities class action for internal-control failures, selling uranium at roughly its own delivered cost, and diluting shareholders to fund a ramp that must still close a large produce-vs-deliver gap.
- Q1 FY2026 uranium cleared at roughly delivered cost ($68.02/lb cost vs $67.78/lb price); the headline profit was a $34.4M one-time New Mexico asset-sale gain - core operations lose money
- Material-weakness disclosure, an FY2024 $67.99M net loss ($61.4M attributable), and the Zhongjian v. enCore securities class action are unresolved credibility and financial risks
- Own extraction (90,000 lb in Q1) trails deliveries (270,000 lb) - the gap is filled with purchased pounds at $78.82/lb that erase margin, and the 3-5M lb/yr targets remain unproven
- $115M convertible debt due 2030 plus a track record of equity/warrant dilution weigh on per-share value
- Lower-cost peers (UEC total cost ~$34-36/lb: FY2025 $36.41, Q1 FY2026 $34.35) and larger producers (Energy Fuels >1M lb finished U3O8 in 2025) leave enCore mid-pack on cost despite its ISR-volume lead
What it is worth
Peer read-across on P/sales plus a commodity-producer sanity check. enCore trades at ~$257M market cap on $43.22M TTM revenue (~6x sales), a discount to healthier ISR peers that reflects the litigation, material-weakness, and near-breakeven-operating-margin overhangs. A per-pound-of-in-ground-resource cross-check points the same direction (discount to peers), but enCore's total resource estimate is not independently confirmed here and is treated as approximate.
~$0.50-0.90/sh
extraction keeps trailing deliveries (persistent purchased-pound losses), a costly litigation outcome and/or further dilution, and a uranium-price pullback compress the equity.
~$1.20-1.80/sh
modest volume growth, margins hover near breakeven at the delivered-cost line, litigation resolves within a manageable range; roughly the current price reflecting the turnaround discount.
~$2.50-3.50/sh
production ramp reaches a multi-million-lb run-rate at ~$35/lb cash cost into $75+/lb pricing, litigation settles cheaply, and the equity re-rates toward UEC/URG sales multiples.
The equity is priced as a distressed turnaround, not a clean growth producer. It re-rates only if (a) own-extraction closes the gap to deliveries and turns operations FCF-positive, (b) the material weakness is remediated and the litigation resolved, and (c) uranium prices hold above the legacy book. Absent (a)-(b), a peer discount is warranted. Not financial advice.
SWOT
Strengths
- Largest ISR uranium producer in the US (699,807 lb extracted FY2025) with two operating central processing plants - a licensed, permitted, cash-flowing production base that peers are still building
- Low cash extraction cost ($34.94/lb Q1 FY2026) leaves a wide margin over price when priced against $70+/lb spot on own-produced pounds
- Contracted book (~8.3M lb committed 2025-2033, twelve US-utility sales agreements per FY2024 10-K) with market/hybrid/base-escalated pricing provides revenue visibility
- Strong domestic-supply positioning as US utilities and government de-risk away from Russian/Kazakh supply
- Optionality-rich balance sheet — $84.7M liquidity including a 23.8M-share stake in Ur-Energy (URG) and other marketable securities, plus Verdera Energy equity retained from the New Mexico sale
Weaknesses
- 2024 material weakness in internal controls over financial reporting and an FY2024 net loss of $67.99M ($61.4M attributable) drove a ~46% one-day crash (2025-03-03) and an ongoing securities class action (Zhongjian v. enCore, S.D. Tex.) - a credibility overhang
- Uranium sold at/near total delivered cost in Q1 FY2026 ($68.02/lb cost vs $67.78/lb realized) - core operations are not yet reliably profitable
- Reliance on purchased pounds (180,000 lb at $78.82/lb in Q1 FY2026) to meet deliveries when own extraction lags inflates cost of sales and caps margin
- Reported profitability depends on one-time asset sales (New Mexico -> Verdera, $34.4M gain), not core mining
- Leadership churn — new CEO Richard Little (effective 2026-04-20, replacing acting CEO Robert Willette) and founder William Sheriff back as Executive Chair signal a turnaround-in-progress, not stability
Opportunities
- Scaling extraction toward 3-5M lb/yr would spread fixed costs and shrink the purchased-pound drag, moving the model toward FCF-positive
- Higher uranium prices flowing into new, better-priced contracts as the legacy book rolls
- US federal support for domestic uranium/enrichment (strategic reserve, HALEU, reactor buildout) lifting long-term demand
- Sector consolidation — management has flagged M&A; enCore could be acquirer or target given its licensed production base
Threats
- Uranium price reversal toward contract floors would compress or eliminate margin on uncontracted pounds
- Litigation and any SEC scrutiny escalating into fines, settlements, or further governance disruption
- Execution risk on the production ramp — ISR grades and well-field performance can disappoint, widening the produce-vs-deliver gap
- Dilution from the $115M convertible (conversion price $3.29, due 2030) if the shares recover, plus prior equity/warrant issuance
- Lower-cost peers (UEC total cost ~$34-36/lb) and larger producers (Energy Fuels >1M lb in 2025, Cameco) competing on cost and contract terms
Moats, dependencies & bottlenecks
Moats
operating US ISR production base (2 central plants, South Texas) NRC/state permitting and well-field licensing take years - the hardest barrier to entry in US uranium, and enCore's most defensible asset.
~8.3M lb committed 2025-2033 across twelve sales agreements (per FY2024 10-K) gives revenue visibility, but pricing is mixed and contracts roll off.
Weak-to-Moderate Real at the cash line but undercut by non-cash costs and purchased-pound reliance; UEC runs a lower total cost.
A relative title, not a cost or contract moat; UEC has a larger resource base and Energy Fuels a larger finished-uranium output.
Dependencies
Revenue is spot-referenced within contract terms; a sustained drop compresses margin and kills uncontracted upside.
Customer concentration A concentrated set of utilities under long-dated sales agreements; sticky but concentrated.
When extraction lags deliveries, enCore buys pounds at market ($78.82/lb in Q1 FY2026) to fulfill contracts, inflating COGS - the central margin risk.
Growth ramp is not self-funding; depends on the $115M 2030 converts and possible further issuance - dilution/refinancing risk.
Expansion requires ongoing permits; also the shield that keeps competitors out.
Advantages
- Only at-scale, licensed pure-play US ISR uranium producer by extracted volume
- Existing multi-million-pound US-utility contract book
- Marketable-securities cushion (23.8M-share URG stake plus others) supplementing liquidity
- Clear leverage to the US domestic-uranium policy tailwind
Weaknesses
- Core operations not yet profitable; profits reliant on asset sales/securities gains
- Internal-control material weakness and active securities class action
- Purchased-pound reliance inflating cost of sales to just above realized price
- Higher total cost and unproven scale-up versus lower-cost peers
- Dilution overhang from the convertible and prior equity/warrant issuance
Bottlenecks
- Own-production throughput — extraction (90k lb/qtr) must catch up to deliveries (270k lb/qtr) to remove purchased-pound margin drag
- Well-field development and satellite/central plant commissioning pace gating the 3-5M lb/yr targets
- Balance-sheet capacity to fund capex without excessive dilution
- Resolution of the securities litigation and remediation of the internal-control material weakness
Top signals & trends
Top signals
Bullish if it closes · 90k extracted vs 270k delivered in Q1 FY2026 - the single most important operational KPI; closing it flips unit economics positive.
Bearish overhang until resolved · Removes a governance/financial-liability cloud; watch for settlement size.
Bullish on resolution · Credibility restoration under new CEO Richard Little / Exec Chair William Sheriff.
Improves realized-price trajectory beyond the legacy book.
Sustained pricing above the legacy book is the main revenue lever.
Trends
Structural multi-year demand tailwind favoring licensed US producers like enCore.
Rising long-term U3O8 demand supports contract pricing.
Volatile spot ($70+/lb regime in 2026) helps realized prices but a reversal compresses margin.
enCore could be acquirer or target; management has flagged consolidation.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Oilfield/well-field service & drilling vendors ISR well-field installation, injection/recovery infrastructure - fragmented specialized service providers.
Ion-exchange resin & processing-chemical suppliers Consumables for the IX/elution circuit at central and satellite plants.
Purchased-pound spot market (U3O8 traders/producers) enCore buys spot pounds to cover deliveries when own extraction lags (180,000 lb at $78.82/lb in Q1 FY2026) - a supplier of last resort that pressures margin.
US nuclear utilities (counterparties unnamed) Primary buyers under twelve long-dated (2025-2033) sales agreements with mixed market/hybrid/base-escalated/fixed pricing; concentrated counterparties.
A legacy off-take with a trader alongside the utility book.
Potential government demand under domestic-supply-security programs.
Large US ISR resource base with the Irigaray hub commissioned in FY2025; lower unit cost (FY2025 total $36.41/lb, cash $27.63; Q1 FY2026 total $34.35/lb) but still ramping drummed volume - the direct, lower-cost ISR rival.
America's largest uranium producer by finished output (>1M lb U3O8 in 2025 at White Mesa Mill, Utah); conventional milling + rare-earth diversification.
Wyoming ISR producer (Lost Creek) scaling up; enCore itself holds 23.8M URG shares as marketable securities.
Global uranium major (Canada/Kazakhstan JV) - sets the contract-pricing environment enCore sells into; the sector benchmark, not ISR-comparable.
Athabasca ISR developer (Wheeler River/Phoenix) advancing toward production; future ISR competitor.
Large Athabasca (Arrow) development-stage hard-rock project; long-dated supply threat, not near-term ISR overlap.